US-Listed Biological Products, (No Diagnostic Substances) — Operating Income Percentiles, FY 2023

Population: 185 US-listed companies (SIC 2836), fiscal year 2023; fiscal year ends 2023-06-30 to 2024-04-30.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile	$-250.5M
25th percentile	$-141.4M
Median	$-65.5M
75th percentile	$-14.1M
90th percentile	$-2.2M
Mean	$-31.9M
Minimum	$-4.2B
Maximum	$7.9B

Methodology & sources
Operating Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2023 = fiscal years ending 2023-06-01 to 2024-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest Operating Income percentiles (live) · All Biological Products, (No Diagnostic Substances) benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2836/operating-income/2023